Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis

BACKGROUND: To estimate the cost -utility of imrecoxib compared with diclofenac, as well as the addition of a proton pump inhibitor to both two treatment strategies, for patients with osteoarthritis, from a Chinese healthcare perspective. METHODS: A Markov model was built. Costs of managing osteoart...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xueshan, Zhen, Xuemei, Hu, Xiaoqian, Li, Yuanyuan, Gu, ShuYan, Gu, Yuxuan, Zhao, Zixuan, Yang, Wei, Dong, Hengjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056517/
https://www.ncbi.nlm.nih.gov/pubmed/33879168
http://dx.doi.org/10.1186/s12962-021-00275-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056517/
https://www.ncbi.nlm.nih.gov/pubmed/33879168
http://dx.doi.org/10.1186/s12962-021-00275-7

Ejemplares similares